Discover 2,023 paid clinical trials in Boca Raton, Florida. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 2,023
PRimary IndividualiZed Evaluation of Cardiovascular Events in Patients With Diabetes Mellitus Using hemoTAG
for
Diabetes Mellitus Type 2, Cardiovascular Diseases,
Location: West Palm Beach FL
Sponsor: Aventusoft, LLC.
Sex: All
Age: 40+
Code: NCT06567795
Recruiting
Evaluation of the Fully Closed Loop Omnipod® System in Type 2 Diabetes
for
Type 2 Diabetes Mellitus
Location: West Palm Beach FL, Wilmington NC, Atlanta GA,
Sponsor: Insulet Corporation
Sex: All
Age: 18 - 70+
Code: NCT07521475
Recruiting
Valve Hemodynamic Optimization Based on Doppler-Echocardiography vs Catheterization Measurements Following ViV TAVR
Location: Pembroke Pines FL, Tampa FL, Oklahoma City OK,
Sponsor: DexCom, Inc.
Sex: All
Age: 2+
Code: NCT03340831
Recruiting
A Trial of the Efficacy and Safety of a Fixed Dose of SEP-363856 in Adults With Generalized Anxiety Disorder
for
Generalized Anxiety Disorder
Location: Hallandale FL, Orlando FL, Memphis TN, Fairfax VA,
Sponsor: Otsuka Pharmaceutical Development & Commercialization, Inc.
Sex: All
Age: 18+
Code: NCT07767903
Phase 3, Recruiting
A Study of Opevesostat (MK-5684) Versus Alternative Next-generation Hormonal Agent (NHA) in Metastatic Castration-resistant Prostate Cancer (mCRPC) Post One NHA (MK-5684-004)
for
Metastatic Castration-resistant Prostate Cancer (mCRPC),
Cantharidin Application in Patients With Common Warts (Verruca Vulgaris) (COVE-3)
for
Common Warts, Common Warts (Verruca Vulgaris),
Location: West Palm Beach FL, Sweetwater FL, Jacksonville FL,
Sponsor: Verrica Pharmaceuticals Inc.
Sex: All
Age: 2+
Code: NCT07637734
Phase 3, Recruiting
Testing the Addition of an IDH2 Inhibitor, Enasidenib, to Usual Treatment (Cedazuridine-Decitabine) for Higher-Risk Myelodysplastic Syndrome (MDS) With IDH2 Mutation (A MyeloMATCH Treatment Trial)
Comparing New Treatments for People With Newly Diagnosed Acute Myeloid Leukemia That Has an IDH2 Gene Change (A MyeloMATCH Treatment Trial)
for
Acute Myeloid Leukemia
Location: Pembroke Pines FL, Miami FL, Augusta GA, Greenville SC,
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 18+
Code: NCT06672146
Phase 2, Recruiting
Testing the Addition of Venetoclax or Gemtuzumab Ozogamicin (GO) to Usual Treatment Regimen (Cytarabine and Daunorubicin, "7+3") for Core Binding Factor Acute Myeloid Leukemia (CBF-AML) to Improve Response (A MYELOMATCH Treatment Trial)
Testing New Therapies for Patients With Acute Myeloid Leukemia Who Are Newly Diagnosed and Have Not Yet Started Treatment (A MyeloMATCH Treatment Trial)
Comparing Cytarabine + Daunorubicin Therapy Versus Cytarabine + Daunorubicin + Venetoclax Versus Venetoclax + Azacitidine in Younger Patients With Intermediate Risk AML (A MyeloMATCH Treatment Trial)
A Study of Nemtabrutinib Plus Venetoclax vs Venetoclax + Rituximab (VR) in Second-line (2L) + Relapsed/Refractory (R/R) Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL) (MK-1026-010/BELLWAVE-010).